Walker et al. (2015) showed a clear difference in the distribution of hyperphosphorylated tau load between clinical AD and clinical DLB patients, with the former showing a higher burden in temporal cortex, while the latter in the occipital cortex [21]. This evidence concerns the gene MAPT and Alzheimer disease.